GALENA BIOPHARMA INC COM
RXII
RXII was delisted on the 25th of October, 2011.
92 hedge funds and large institutions have $11.8M invested in GALENA BIOPHARMA INC COM in 2016 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 25 increasing their positions, 23 reducing their positions, and 11 closing their positions.
774% more call options, than puts
Call options by funds: $3.66M | Put options by funds: $419K
18% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 11
2% more funds holding
Funds holding: 90 → 92 (+2)
9% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 23
18% less capital invested
Capital invested by funds: $14.4M → $11.8M (-$2.61M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$517K |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$437K |
| 3 |
Goldman Sachs
New York
|
+$434K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$86.5K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$45.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
-$289K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$94.9K |
| 3 |
MLICM
Metropolitan Life Insurance Company (MetLife)
New York
|
-$71K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$69.8K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$44K |
RXII Hedge Fund Activity: Q3 2016 in Review
92 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in GALENA BIOPHARMA INC COM (RXII) for Q3 2016, worth a combined $11.8M — down 18% from $14.4M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new RXII positions and 11 closed out — a net gain of 2 holders — while 25 added to existing stakes and 23 trimmed.
The largest buyer was Vanguard Group, adding an estimated $517K. The largest seller was Group One Trading, cutting an estimated $289K.
- 92 institutional investors held GALENA BIOPHARMA INC COM (RXII) as of Q3 2016, up from 90 in Q2 2016.
- Funds reported $11.8M of GALENA BIOPHARMA INC COM stock for Q3 2016, down 18% quarter-over-quarter.
- 13 funds opened new GALENA BIOPHARMA INC COM positions in Q3 2016 and 11 closed out, a net change of +2 holders.
- The largest GALENA BIOPHARMA INC COM buyer in Q3 2016 was Vanguard Group, an estimated $517K added.
- The largest GALENA BIOPHARMA INC COM seller in Q3 2016 was Group One Trading, an estimated $289K sold.
Based on aggregated 13F filings for Q3 2016.